CN Stock MarketDetailed Quotes

600518 Kangmei Pharmaceutical

Watchlist
  • 2.15
  • +0.03+1.42%
Market Closed Jul 5 15:00 CST
29.81BMarket Cap179.17P/E (TTM)

Kangmei Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
5.01%1.2B
16.60%4.87B
29.84%3.53B
33.62%2.38B
22.50%1.14B
0.67%4.18B
-11.80%2.72B
-14.04%1.78B
-14.15%933.85M
-23.27%4.15B
Operating revenue
5.01%1.2B
16.60%4.87B
29.84%3.53B
33.62%2.38B
22.50%1.14B
0.67%4.18B
-11.80%2.72B
-14.04%1.78B
-14.15%933.85M
-23.27%4.15B
Other operating revenue
----
149.66%47.3M
----
110.39%24.56M
----
-80.82%18.95M
----
-81.54%11.67M
----
-31.65%98.79M
Total operating cost
3.28%1.27B
0.10%4.89B
26.48%3.84B
30.25%2.58B
17.79%1.23B
-25.00%4.89B
-30.20%3.03B
-38.44%1.98B
-38.82%1.04B
-32.02%6.52B
Operating cost
4.58%1.03B
13.96%4.04B
29.95%2.94B
32.15%1.96B
23.59%982.88M
1.75%3.55B
-10.13%2.26B
-11.85%1.48B
-7.96%795.28M
-33.30%3.49B
Operating tax surcharges
-12.96%11.19M
-240.45%-274.18M
309.03%53.98M
56.77%41.64M
-1.91%12.85M
-70.13%195.22M
-72.57%13.2M
-16.95%26.56M
-25.13%13.1M
431.73%653.49M
Operating expense
-7.72%95.76M
18.24%551.78M
47.21%437.36M
66.86%309.16M
18.46%103.77M
3.74%466.64M
-13.11%297.11M
-25.56%185.28M
-32.94%87.6M
-37.03%449.84M
Administration expense
0.38%126.37M
-18.29%502.12M
-17.11%384.72M
-11.35%254.45M
-17.03%125.9M
-28.24%614.49M
-15.40%464.16M
-21.68%287.04M
-21.23%151.73M
-35.27%856.3M
Financial expense
81.87%-821.58K
-33.59%27.12M
32.18%-13.68M
34.80%-8.92M
36.08%-4.53M
-96.16%40.84M
-102.29%-20.18M
-101.56%-13.69M
-101.42%-7.09M
-51.44%1.06B
-Interest expense (Financial expense)
-0.54%2.99M
-28.83%56.15M
18.79%9.37M
22.13%6.26M
17.73%3M
-92.28%78.9M
-99.06%7.89M
-99.39%5.12M
-99.49%2.55M
-52.78%1.02B
-Interest Income (Financial expense)
48.69%-4.03M
23.19%-30.74M
17.43%-24.54M
18.62%-16.33M
20.79%-7.86M
-659.36%-40.03M
-1,301.73%-29.73M
-1,503.53%-20.06M
-1,650.53%-9.92M
-143.06%-5.27M
Research and development
9.23%10.36M
79.27%45.62M
95.81%37.84M
91.72%23.58M
141.65%9.49M
174.41%25.45M
70.48%19.33M
44.01%12.3M
-6.90%3.93M
-18.36%9.27M
Credit Impairment Loss
46,711.60%13.58M
188.87%202.17M
1,731.73%66.71M
124.81%7.4M
99.78%-29.13K
89.59%-227.48M
85.40%-4.09M
-0.40%-29.83M
-393.08%-13.29M
-106.49%-2.18B
Asset Impairment Loss
-99.54%1.59K
60.26%-197.55M
482.85%782.69K
225.72%736.11K
91.34%348.36K
84.43%-497.16M
-117.67%-204.44K
25.39%-585.5K
-85.02%182.06K
87.37%-3.19B
Other net revenue
121.35%79.11M
110.04%107.27M
1,060.31%162.63M
901.60%86.85M
1,071.37%35.74M
-108.56%-1.07B
-94.51%14.02M
-104.46%-10.83M
-120.00%-3.68M
147.42%12.48B
Fair value change income
---5.26K
---34.51K
---25.85K
---17.45K
----
----
----
----
----
----
Invest income
412.09%29.53M
5,849.29%44.43M
24,761.53%33.31M
285,176.16%21.87M
95,704.45%5.77M
-99.60%746.87K
-99.92%133.97K
-100.00%7.67K
--6.02K
4,212.43%188.79M
Asset deal income
29.59%26.13M
1,902.41%19.61M
3,026.64%20.46M
3,694.12%20.37M
6,459.68%20.16M
-98.47%979.19K
-98.59%654.34K
-98.85%536.9K
-88.35%307.36K
241.48%64.01M
Other revenue
4.10%9.88M
111.20%38.65M
136.28%41.4M
91.62%36.48M
4.15%9.49M
-101.96%-344.99M
-69.73%17.52M
-60.87%19.04M
-8.91%9.11M
23,281.66%17.6B
Operating profit
118.92%9.59M
104.88%86.67M
53.14%-139.12M
45.07%-117.36M
55.70%-50.67M
-117.58%-1.78B
70.42%-296.89M
76.45%-213.67M
80.97%-114.39M
133.16%10.11B
Add:Non operating Income
-92.15%583.5K
81.67%57.88M
-21.95%22.56M
-34.56%17.45M
288.51%7.43M
30.42%31.86M
307.34%28.9M
748.22%26.67M
8.10%1.91M
-26.24%24.43M
Less:Non operating expense
-52.19%508.1K
-96.28%34.18M
-97.37%15.99M
161.22%15.56M
65.97%1.06M
-53.62%918.37M
32,945.70%608.74M
411.66%5.96M
299.53%640.38K
243.91%1.98B
Total profit
121.82%9.66M
104.14%110.37M
84.88%-132.55M
40.16%-115.47M
60.83%-44.3M
-132.67%-2.66B
12.19%-876.73M
78.68%-192.96M
81.14%-113.11M
126.28%8.16B
Less:Income tax cost
-80.75%1.05M
-77.14%6.8M
68.18%13.99M
275.97%9.59M
451.13%5.46M
-87.36%29.75M
-70.88%8.32M
-90.70%2.55M
43.89%-1.56M
276.34%235.39M
Net profit
FLtoP8.61M
FLtoP103.57M
FPtoL-146.54M
FPtoL-125.06M
FPtoL-49.77M
SL-2.69B
FPtoL-885.05M
FPtoL-195.51M
FPtoL-111.56M
FLtoP7.92B
Net profit from continuing operation
117.31%8.61M
103.84%103.57M
83.44%-146.54M
36.03%-125.06M
55.39%-49.77M
-134.01%-2.69B
13.83%-885.05M
79.04%-195.51M
81.31%-111.56M
128.54%7.92B
Less:Minority Profit
77.48%1.14M
118.54%1.05M
103.32%1.47M
488.60%793.21K
575.89%643.19K
-381.56%-5.64M
129.44%723.15K
104.29%134.76K
91.52%-135.15K
117.90%2M
Net profit of parent company owners
114.82%7.47M
103.81%102.52M
83.29%-148.01M
35.67%-125.86M
54.76%-50.41M
-133.95%-2.69B
13.55%-885.77M
78.95%-195.65M
81.28%-111.42M
128.55%7.92B
Earning per share
Basic earning per share
125.00%0.001
105.26%0.01
82.81%-0.011
35.71%-0.009
50.00%-0.004
-133.33%-0.19
13.51%-0.064
79.10%-0.014
93.39%-0.008
110.15%0.57
Diluted earning per share
125.00%0.001
105.26%0.01
82.81%-0.011
35.71%-0.009
50.00%-0.004
-133.33%-0.19
13.51%-0.064
79.10%-0.014
93.39%-0.008
110.15%0.57
Other composite income
-3,977.41%-21.77K
-158.78%-235.82K
-556.27%-13.4K
238.16%8.54K
-533.98
-88.44%401.22K
-98.10%2.94K
-98.41%2.53K
1,481.96%3.47M
Other composite income of parent company owners
-3,977.41%-21.77K
-158.78%-235.82K
-556.27%-13.4K
238.16%8.54K
---533.98
-88.44%401.22K
-98.10%2.94K
-98.41%2.53K
----
1,594.98%3.47M
Total composite income
117.26%8.59M
103.84%103.33M
83.44%-146.55M
36.04%-125.06M
55.39%-49.77M
-133.99%-2.69B
13.81%-885.04M
79.03%-195.51M
81.30%-111.56M
125.48%7.92B
Total composite income of parent company owners
114.78%7.45M
103.81%102.29M
83.29%-148.02M
35.67%-125.85M
54.76%-50.41M
-133.93%-2.69B
13.54%-885.77M
78.95%-195.64M
81.28%-111.42M
128.56%7.92B
Total composite income of minority owners
77.48%1.14M
118.54%1.05M
103.32%1.47M
488.60%793.21K
575.89%643.19K
-381.56%-5.64M
129.44%723.15K
104.29%134.76K
91.52%-135.15K
117.87%2M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion with explanatory notes
Auditor
--
Tianzhu International Accounting Firm (Special General Partnership)
--
--
--
Tianzhu International Accounting Firm (Special General Partnership)
--
--
--
Tianzhu International Accounting Firm (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 5.01%1.2B16.60%4.87B29.84%3.53B33.62%2.38B22.50%1.14B0.67%4.18B-11.80%2.72B-14.04%1.78B-14.15%933.85M-23.27%4.15B
Operating revenue 5.01%1.2B16.60%4.87B29.84%3.53B33.62%2.38B22.50%1.14B0.67%4.18B-11.80%2.72B-14.04%1.78B-14.15%933.85M-23.27%4.15B
Other operating revenue ----149.66%47.3M----110.39%24.56M-----80.82%18.95M-----81.54%11.67M-----31.65%98.79M
Total operating cost 3.28%1.27B0.10%4.89B26.48%3.84B30.25%2.58B17.79%1.23B-25.00%4.89B-30.20%3.03B-38.44%1.98B-38.82%1.04B-32.02%6.52B
Operating cost 4.58%1.03B13.96%4.04B29.95%2.94B32.15%1.96B23.59%982.88M1.75%3.55B-10.13%2.26B-11.85%1.48B-7.96%795.28M-33.30%3.49B
Operating tax surcharges -12.96%11.19M-240.45%-274.18M309.03%53.98M56.77%41.64M-1.91%12.85M-70.13%195.22M-72.57%13.2M-16.95%26.56M-25.13%13.1M431.73%653.49M
Operating expense -7.72%95.76M18.24%551.78M47.21%437.36M66.86%309.16M18.46%103.77M3.74%466.64M-13.11%297.11M-25.56%185.28M-32.94%87.6M-37.03%449.84M
Administration expense 0.38%126.37M-18.29%502.12M-17.11%384.72M-11.35%254.45M-17.03%125.9M-28.24%614.49M-15.40%464.16M-21.68%287.04M-21.23%151.73M-35.27%856.3M
Financial expense 81.87%-821.58K-33.59%27.12M32.18%-13.68M34.80%-8.92M36.08%-4.53M-96.16%40.84M-102.29%-20.18M-101.56%-13.69M-101.42%-7.09M-51.44%1.06B
-Interest expense (Financial expense) -0.54%2.99M-28.83%56.15M18.79%9.37M22.13%6.26M17.73%3M-92.28%78.9M-99.06%7.89M-99.39%5.12M-99.49%2.55M-52.78%1.02B
-Interest Income (Financial expense) 48.69%-4.03M23.19%-30.74M17.43%-24.54M18.62%-16.33M20.79%-7.86M-659.36%-40.03M-1,301.73%-29.73M-1,503.53%-20.06M-1,650.53%-9.92M-143.06%-5.27M
Research and development 9.23%10.36M79.27%45.62M95.81%37.84M91.72%23.58M141.65%9.49M174.41%25.45M70.48%19.33M44.01%12.3M-6.90%3.93M-18.36%9.27M
Credit Impairment Loss 46,711.60%13.58M188.87%202.17M1,731.73%66.71M124.81%7.4M99.78%-29.13K89.59%-227.48M85.40%-4.09M-0.40%-29.83M-393.08%-13.29M-106.49%-2.18B
Asset Impairment Loss -99.54%1.59K60.26%-197.55M482.85%782.69K225.72%736.11K91.34%348.36K84.43%-497.16M-117.67%-204.44K25.39%-585.5K-85.02%182.06K87.37%-3.19B
Other net revenue 121.35%79.11M110.04%107.27M1,060.31%162.63M901.60%86.85M1,071.37%35.74M-108.56%-1.07B-94.51%14.02M-104.46%-10.83M-120.00%-3.68M147.42%12.48B
Fair value change income ---5.26K---34.51K---25.85K---17.45K------------------------
Invest income 412.09%29.53M5,849.29%44.43M24,761.53%33.31M285,176.16%21.87M95,704.45%5.77M-99.60%746.87K-99.92%133.97K-100.00%7.67K--6.02K4,212.43%188.79M
Asset deal income 29.59%26.13M1,902.41%19.61M3,026.64%20.46M3,694.12%20.37M6,459.68%20.16M-98.47%979.19K-98.59%654.34K-98.85%536.9K-88.35%307.36K241.48%64.01M
Other revenue 4.10%9.88M111.20%38.65M136.28%41.4M91.62%36.48M4.15%9.49M-101.96%-344.99M-69.73%17.52M-60.87%19.04M-8.91%9.11M23,281.66%17.6B
Operating profit 118.92%9.59M104.88%86.67M53.14%-139.12M45.07%-117.36M55.70%-50.67M-117.58%-1.78B70.42%-296.89M76.45%-213.67M80.97%-114.39M133.16%10.11B
Add:Non operating Income -92.15%583.5K81.67%57.88M-21.95%22.56M-34.56%17.45M288.51%7.43M30.42%31.86M307.34%28.9M748.22%26.67M8.10%1.91M-26.24%24.43M
Less:Non operating expense -52.19%508.1K-96.28%34.18M-97.37%15.99M161.22%15.56M65.97%1.06M-53.62%918.37M32,945.70%608.74M411.66%5.96M299.53%640.38K243.91%1.98B
Total profit 121.82%9.66M104.14%110.37M84.88%-132.55M40.16%-115.47M60.83%-44.3M-132.67%-2.66B12.19%-876.73M78.68%-192.96M81.14%-113.11M126.28%8.16B
Less:Income tax cost -80.75%1.05M-77.14%6.8M68.18%13.99M275.97%9.59M451.13%5.46M-87.36%29.75M-70.88%8.32M-90.70%2.55M43.89%-1.56M276.34%235.39M
Net profit FLtoP8.61MFLtoP103.57MFPtoL-146.54MFPtoL-125.06MFPtoL-49.77MSL-2.69BFPtoL-885.05MFPtoL-195.51MFPtoL-111.56MFLtoP7.92B
Net profit from continuing operation 117.31%8.61M103.84%103.57M83.44%-146.54M36.03%-125.06M55.39%-49.77M-134.01%-2.69B13.83%-885.05M79.04%-195.51M81.31%-111.56M128.54%7.92B
Less:Minority Profit 77.48%1.14M118.54%1.05M103.32%1.47M488.60%793.21K575.89%643.19K-381.56%-5.64M129.44%723.15K104.29%134.76K91.52%-135.15K117.90%2M
Net profit of parent company owners 114.82%7.47M103.81%102.52M83.29%-148.01M35.67%-125.86M54.76%-50.41M-133.95%-2.69B13.55%-885.77M78.95%-195.65M81.28%-111.42M128.55%7.92B
Earning per share
Basic earning per share 125.00%0.001105.26%0.0182.81%-0.01135.71%-0.00950.00%-0.004-133.33%-0.1913.51%-0.06479.10%-0.01493.39%-0.008110.15%0.57
Diluted earning per share 125.00%0.001105.26%0.0182.81%-0.01135.71%-0.00950.00%-0.004-133.33%-0.1913.51%-0.06479.10%-0.01493.39%-0.008110.15%0.57
Other composite income -3,977.41%-21.77K-158.78%-235.82K-556.27%-13.4K238.16%8.54K-533.98-88.44%401.22K-98.10%2.94K-98.41%2.53K1,481.96%3.47M
Other composite income of parent company owners -3,977.41%-21.77K-158.78%-235.82K-556.27%-13.4K238.16%8.54K---533.98-88.44%401.22K-98.10%2.94K-98.41%2.53K----1,594.98%3.47M
Total composite income 117.26%8.59M103.84%103.33M83.44%-146.55M36.04%-125.06M55.39%-49.77M-133.99%-2.69B13.81%-885.04M79.03%-195.51M81.30%-111.56M125.48%7.92B
Total composite income of parent company owners 114.78%7.45M103.81%102.29M83.29%-148.02M35.67%-125.85M54.76%-50.41M-133.93%-2.69B13.54%-885.77M78.95%-195.64M81.28%-111.42M128.56%7.92B
Total composite income of minority owners 77.48%1.14M118.54%1.05M103.32%1.47M488.60%793.21K575.89%643.19K-381.56%-5.64M129.44%723.15K104.29%134.76K91.52%-135.15K117.87%2M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion with explanatory notes
Auditor --Tianzhu International Accounting Firm (Special General Partnership)------Tianzhu International Accounting Firm (Special General Partnership)------Tianzhu International Accounting Firm (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg